Biocept (BIOC) Misses Q3 EPS by $0.03

Biocept (NASDAQ: BIOC) reported Q3 EPS of $0.03, $0.03 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $17.5 million versus the consensus estimate of $16.07 million.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Financial Select Sector SPDR ETF (XLF) spreader of 20K contracts of July 31 weekly 57 and 59 calls into bank earnings season
• UBS Reiterates Neutral Rating on Buckle, Inc. (BKE)